403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Exosome Research Market Size To Reach USD 961.41 Million By 2034
| Report Attribute | Details |
| Market size value in 2025 | USD 225.72 million |
| Revenue forecast in 2033 | USD |
| Growth rate | CAGR of 17.47% from 2025 to 2034 |
| Actual data | 2021 - 2024 |
| Forecast period | 2025 - 2034 |
| Quantitative units | Revenue in USD million and CAGR from 2025 to 2034 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Product Type, By Application, By Workflow, By End User, By Region |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait; Qatar; Oman |
| Key companies profiled | Thermo Fisher Scientific, Bio-Techne Corporation, System Biosciences (SBI), QIAGEN, NanoView Biosciences, Miltenyi Biotec, Danaher Corporation, Exosome Diagnostics, Lonza, Norgen Biotek Corp, Malvern Panalytical, NanoFCM, Creative Biolabs, AMS Biotechnology, Evox Therapeutics, HansaBioMed Life Sciences, Diagenode, Exosomics, Aruna Bio, Labcorp Drug Development |
| Customization scope | Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
What are the Ongoing Trends in the Exosome Research Market?
- In June 2025, Rion Aesthetics, an internationally recognized regenerative aesthetics company, announced that the U.S. Food and Drug Administration (FDA) had allowed an Investigational New Drug (IND) application to proceed for a Phase 1 investigator-initiated trial evaluating Purified Exosome Product injected into the dermis. The study is sponsored and independently conducted by Clinical Testing Center of Beverly Hills and is being led by Dr. John H. Joseph, a double board-certified facial plastic surgeon based in California. In April 2025, QIAGEN N.V. announced a series of product and partnership updates designed to strengthen its portfolio for cancer genomic profiling. New QIAseq panels launched for use on next-generation sequencers to boost analysis of over 700 genes for comprehensive genomic profiling in research and clinical applications In July 2025, Exosome Diagnostics Inc., a leader in the liquid biopsy market, announced the close of its $30 million Series C financing, led by insiders, Tiger Partners and Forbion Capital Partners. Blue Ridge Capital, NGN Capital, Arcus Ventures, b-to-v Partners, CD Ventures, and others participated in the round, which was oversubscribed.
What is the Emerging Challenge in the Exosome Research Market?
A requirement for greater initial spending in research, multifaceted and ineffective cell detachment technology, government obstacles, and the need for standardization and skilled labor are creating significant limitations in the overall exosome research market growth.
Regional Analysis
Why did North America Dominate the Market in 2024?
By capturing a major share, North America registered dominance in the market in 2024 a well-established medical care substructure, substantial R&D spending, the strong presence of key market players, and favorable government initiatives and reimbursement guidelines. North America is a hub of many healthcare organizations in the sequencing field, including Illumina, Thermo Fisher Scientific, and Agilent Technologies. Growing government initiative, for instance, in October 2025, GeneDx announced the first U.S. national genomic newborn screening initiative launched with $14.4 million NIH award.
How did the Asia Pacific Grow Notably in the Market in 2024?
During 2025-2034, the Asia Pacific is anticipated to expand at a rapid CAGR in the exosome research market as many emerging Asian economies, including Indonesia, India, and the Philippines, are expected to experience strong growth driven by vigorous domestic investment. The region cooperatively outperformed global growth prospects and cemented its role as a leading contributor to the biosphere economy. Growing spend in research and technology, for instance, South Korea's Korea Drug Development Fund (KDDF) has committed US$1.6 billion to over 1,200 projects by 2030
Immediate Delivery Available | Buy This Premium Research (Global Deep Dive USD 3800)Segmental Insights
By product type analysis
Which Product Type Led the Exosome Research Market in 2024?
The reagents and kits segment accounted for the dominating share of the market in 2024, as profitable exome capture kits offer a significantly effective way to sequence a select region of the genome at very high precision. It offers scientists the capabilities to use sequencing and analysis resources more predominantly by focusing on the most relevant share of the genome.
Whereas the RNA
By application analysis
How did the Cancer Research Segment Dominate the Market in 2024?
In 2024, the cancer research segment captured the biggest share of the exosome research market as cancer exome sequencing enables scientists to assess only coding regions, which often contain alterations that affect tumor development. Using NGS technology gives investigators more inclusive data and more detection power than achieved through PCR.
Although the drug delivery systems segment will expand fastest during 2025-2034, as exosomes show exclusive biocompatibility, low immunogenicity, and lower toxicity. Furthermore, exosomes are designed and tailored to enhance targeting effectiveness, cargo loading capacity, and stability, creating the way for targeted medicine and accurate therapy. An exosome-based delivery system has specifically advantages, like safety, specificity, and stability.
By workflow analysis
Which Type of Workflow Dominated the Exosome Research Market in 2024?
The isolation segment captured the largest share of the market in 2024 as appropriate isolation eliminates impurities such as RNA, proteins, lipids, and other cellular debris that interfere with subsequent enzymatic reactions. This is significant for generating clean and reliable sequencing information. Effective isolation protocols, particularly those involving appropriate sample handling and storage, support to prevent the degradation of DNA by nucleases.
On the other hand, the microfluidics-based isolation segment will expand rapidly as microfluidic-based exosome separation has been reported to be rapid and more efficient than conventional techniques because of the various forces generated by electric and acoustic fields and hydrodynamic forces. Different microfluidic devices that utilize dielectrophoretic (DEP) forces have been industrialized to capture and isolate exosomes.
By application analysis
Why did the Vaccine Manufacturing Segment Lead the Market in 2024?
The vaccine manufacturing segment accounted for a dominant share of the Exosome Research Market in 2024, as the broader acceptance of microcarriers provides a high-surface-area platform for anchoring-driven cells, enabling greater cell densities and volumes of vaccine to be manufactured in a limited time compared to conventional strategies. The exploration of SUBs is enabling many benefits for vaccine manufacturing with the lower risk of contamination, omission of sterilization and cleaning steps, and radically lowering the turnaround time in the production batches.
However, the cell therapy regenerative medicine
By end-user analysis
How did the Academic and Research Institutes Segment Dominate the Market in 2024?
The academic & research institutes segment held the biggest share of the exosome research market in 2024, as academic centers are instrumental in the discovery of new disease-causing variants and genes, particularly for rare Mendelian disorders and multifaceted traits. Academic institutions drive large-scale, population-based research that generates massive amounts of information.
On the other hand, the pharmaceutical biotechnology
Top Companies in the Exosome Research Market
- Thermo Fisher Scientific Bio-Techne Corporation System Biosciences (SBI) QIAGEN NanoView Biosciences Miltenyi Biotec Danaher Corporation Exosome Diagnostics Lonza Norgen Biotek Corp Malvern Panalytical NanoFCM Creative Biolabs AMS Biotechnology Evox Therapeutics HansaBioMed Life Sciences Diagenode Exosomics Aruna Bio Labcorp Drug Development
What are the Recent Developments in the Exosome Research Market?
- In October 2025, as per DelveInsight's assessment, globally, the Exosomes pipeline constitutes 80+ key companies continuously working towards developing 100+ Exosomes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. In August 2025, mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne, including the ExoDx Prostate (EPI) test, a CLIA-certified clinical laboratory, and related assets. Total consideration for the acquisition is $15 million, with $5 million in stock paid at closing and $2.5 million to be paid annually over the following 4 years, with 50% in cash and 50% in cash or stock at MDXHealth's discretion.
More Insights in Nova One Advisor:
- Chemiluminescence Immunoassay Market - The global chemiluminescence immunoassay market size Healthcare Business Intelligence Market - The global healthcare business intelligence market size Plasma Fractionation Market - The plasma fractionation market size Middle East Patient Engagement Solutions Market - The Middle East patient engagement solutions market size U.S. Credentialing Software And Services In Healthcare Market - The U.S. credentialing software and services in healthcare market AI in Clinical Trials Market - The global AI in clinical trials market size Middle East Digital Health Market - The Middle East digital health market Biopharmaceutical Third-party Logistics Market - The global biopharmaceutical third-party logistics size Women's Health App Market - The women's health app market size Remote Healthcare Market - The global Remote Healthcare market Patient Positioning Systems Market - The global Patient Positioning Systems market Cell Expansion Market - The global cell expansion market size
Exosome research Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. For this study, Nova One Advisor has segmented the global exosome research Market
Segments Covered in the Report
By Product Type
- Instruments
- Ultracentrifuges Nanoparticle Tracking Analyzers Flow Cytometers Others
- Isolation Kits Labeling & Detection Kits RNA/DNA Extraction Kits Antibodies Others
- Services Custom Isolation Services Exosome Profiling Services Exosome Engineering Services Others
By Application
- Cancer Research Neurodegenerative Disease Research Cardiovascular Disease Research Infectious Disease Research Drug Delivery Systems Biomarker Discovery Others
By Workflow
- Isolation
- Ultracentrifugation Size-exclusion Chromatography Immunoaffinity Capture Microfluidics-based Isolation Precipitation Others
- NTA (Nanoparticle Tracking Analysis) Western Blotting Electron Microscopy DLS (Dynamic Light Scattering) ELISA Others
- Proteomics Genomics Lipidomics Others
By End User
- Academic & Research Institutes Pharmaceutical & Biotechnology Companies Clinical Laboratories Hospitals CROs & CDMOs Others
By Regional
- North America Europe Asia Pacific Latin America Middle East and Africa (MEA)
About-Us
Nova One Advisor is a global leader in market intelligence and strategic consulting, committed to delivering deep, data-driven insights that power innovation and transformation across industries. With a sharp focus on the evolving landscape of life sciences, we specialize in navigating the complexities of cell and gene therapy, drug development, and the oncology market, enabling our clients to lead in some of the most revolutionary and high-impact areas of healthcare.
Our expertise spans the entire biotech and pharmaceutical value chain, empowering startups, global enterprises, investors, and research institutions that are pioneering the next generation of therapies in regenerative medicine, oncology, and precision medicine.
Our Trusted Data Partners
Towards Chemical and Materials | Precedence Research | Statifacts | Towards Packaging | Towards Healthcare | Towards Food and Beverages | Towards Automotive | Towards Consumer Goods | Nova One Advisor | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics | Towards Chem and Material Web:Contact Us
USA: +1 804 420 9370
Email: ... For Latest Update Follow Us: LinkedIn
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment